WINT : Insider Transactions for Windtree Therapeutics Inc | J3SG

Sign in:	Email	Password save:

		Company Reports
Find Symbol

Recent: Companies Filers Institutions

Membership is free, please Sign Up.

My Recent Searches

Help

Roster

Institutions

Add To Portfolo/Alerts

Get Insiders for :

Windtree Therapeutics Inc (WINT)

$0.16 0.00 (0.00%) as of 4:30 Thu 2/23

Download

Exchange:

Nasdaq National Market

Security Type:

Common

Shares Out:

16,920,000

Market Cap:

2.77(M)

Last Volume:

25,688,722

Avg Vol:

24,219,673

52 Week Range:

$0.164 - $0.164

Level I Sector:

Health Care

Level II Sector:

Drugs

Level III Sector:

Biotechnology

Member Indexes:

	NASDAQ BIOTECHNOLOGY		NASDAQ COMPOSITE
	NASDAQ NNM COMPOSITE

Rankings:

Insider 3 Months : -

Insider 6 Months : -

Insider 3/6 Months : -

Guru Rank Number : -

Guru Rank Value : -

Guru Occurances : -


6 Months 1 Year 2 Year

Company Profile Windtree Therapeutics is a clinical-stage, biopharmaceutical company focused on the development of therapeutics to address unmet medical needs in acute care markets. Co.'s primary product candidate, istaroxime, is a dual-acting agent being developed to improve cardiac function in patients with acute heart failure. In addition, Co. cardiovascular drug product candidates include rostafuroxin, for the treatment of hypertension in patients with a specific genetic profile. Co.'s pulmonary product candidate portfolio consists of a KL4 surfactant platform to address a range of serious respiratory conditions in children and adults.

D/I:

D is for direct shares.
I is for indirect shares.

D/I refers to the Direct or Indirect shares traded vs. held.

Forms:

A Form 4 is a form filed by an insider to indicate a change in ownership.

A Form 3 is a form filed by an insider to indicate an initial ownership of a security.

3m +/-:

This represents the company's 3 month price change. The initial price is based on the closing price of the stock on the day the transaction took place. Purchases & sales are viewed as long & short positions respectively.

Actions:

B	Buy
S	Sell
OE	Option Exercised
A	Acquired
D	Disposed
AB	Automatic Buy
AS	Automatic Sell
IO	Initial Ownership

Download:

Download only Transactions Forms. (Default)

Download only Summary Infomation.

Download both Transactions and Summary Data

Summary (Direct Transactions Only)	3 Months	6 Months	12 Months	24 Months
Total Shares Bought	0	0	2,500	24,812
Total Buy Value	$0	$0	$2,250	$15,204
Total People Bought	0	0	1	2
Total Buy Transactions	0	0	1	8
Total Shares Sold	0	0	0	0
Total Sell Value	$0	$0	$0	$0
Total People Sold	0	0	0	0
Total Sell Transactions	0	0	0	0
End Date	2024-02-18	2023-11-17	2023-05-19	2022-05-19

Adjust Filter Settings

Records found: 619

Page 13 of 25

Filer's Name

Relation Title

Off-Dir-10%

D/I

Rank

3m +/-

Form

Tattory John Andrew

VP, Princ Acct Officer

• – –

2010-09-30

5

A

$3.15

$1,799

I/I

571

2,716

-

President & CFO

• – –

2010-09-30

5

A

$3.15

$2,060

I/I

654

3,931

-

Miller Thomas F

Chief Operating Officer

• – –

2010-09-30

5

A

$3.15

$2,060

I/I

654

3,760

-

Senior VP, Human Resources

• – –

2010-09-30

5

A

$3.15

$2,060

I/I

654

3,639

-

Executive VP & Legal Counsel

• – –

2010-09-30

4

A

$0.21

$1,961

I/I

9,337

47,722

-

VP, ManufacturingOfficer

• – –

2010-09-30

3

IO

$0.00

$0

D/D

0

100,000

-

President & CFO

• – –

2010-09-27

4

A

$0.00

$0

D/D

300,000

339,688

-

Miller Thomas F

Chief Operating Officer

• – –

2010-09-27

4

A

$0.00

$0

D/D

225,000

231,895

-

Senior VP, Human Resources

• – –

2010-09-27

4

A

$0.00

$0

D/D

175,000

175,000

-

Tattory John Andrew

VP, Principal Acct Officer

• – –

2010-09-27

4

A

$0.00

$0

D/D

100,000

100,000

-

Executive VP & Legal Counsel

• – –

2010-09-27

4

A

$0.00

$0

D/D

225,000

278,834

-

Tattory John Andrew

VP, Principal Acct OfficerOffi

• – –

2010-08-24

3

IO

$0.00

$0

I/I

0

23,681

-

Segal Robert-Md

Senior VP, Sci & Med Affairs

• – –

2010-06-30

5

A

$2.85

$2,061

I/I

723

3,930

-

Senior VP, Human Resources

• – –

2010-06-30

4

A

$0.19

$2,063

I/I

10,857

35,049

-

Segal Robert-Md

SVO, Chief Medical Officer

• – –

2010-06-30

4

A

$0.19

$2,062

I/I

10,855

39,415

-

Miller Thomas F

SVP, Commercial & Corp Dev

• – –

2010-06-30

4

A

$0.19

$2,063

I/I

10,857

36,852

-

Executive VP & CFO

• – –

2010-06-30

4

A

$0.19

$2,063

I/I

10,857

39,417

-

Executive VP & Legal Counsel

• – –

2010-06-30

4

A

$0.19

$2,164

I/I

11,390

38,385

-

Senior VP, Human Resources

• – –

2010-03-31

4

A

$0.52

$2,062

I/I

3,966

24,192

-

Segal Robert-Md

SVO, Chief Medical Officer

• – –

2010-03-31

4

A

$0.52

$2,063

I/I

3,967

28,560

-

Miller Thomas F

SVP, Commercial & Corp Dev

• – –

2010-03-31

4

A

$0.52

$2,062

I/I

3,966

25,995

-

Executive VP & CFO

• – –

2010-03-31

4

A

$0.52

$2,062

I/I

3,966

28,560

-

Executive VP & Legal Counsel

• – –

2010-03-31

4

A

$0.52

$1,875

I/I

3,606

26,995

-

Executive VP & CFO

• – –

2010-01-03

4/A

D

$0.63

$2,087

D/D

(3,312)

39,688

-

Segal Robert-Md

SVO, Chief Medical Officer

• – –

2010-01-03

4

D

$0.63

$927

D/D

(1,472)

4,528

-

619 Records found	Previous 10 11 12 13 14 15 16 17 18 19 Next	Page 13 of 25

	Transaction Code Key:				Ownership Code Key
	B	- Buy	AB	- Automatic Buy	D	- Direct Ownership
	S	- Sell	AS	- Automatic Sell	I	- Indirect Ownership
	OE	- Options Exercised	A	- Acquired
	IO	- Initital Ownership	D	- Disposed

Copyright © 2024 j3sg.com | Disclaimer & Terms of use Products & Service About Us Contact Us

Summary:

Chart:

3m +/-:

This represents the company's 3 month price change. The initial price is based on the closing price of the stock on the day the transaction took place. Purchases & sales are viewed as long & short positions respectively.